- Home
- european to american bra sizes
- The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients
The Birmingham Epidermolysis Bullosa Severity (BEBS) score of EB patients
4.7 (741) · $ 19.00 · In stock
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract
Managing pain in children with epidermolysis bullosa
RDEB Wounds May Benefit From Omalizumab, Small Study Finds
Baseline demographics of patients with epidermolysis bullosa included
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract
Understanding the socioeconomic costs of dystrophic epidermolysis bullosa in Europe: a costing and health-related quality of life study, Orphanet Journal of Rare Diseases
Epidermolysis bullosa Nature Reviews Disease Primers
Epidermolysis bullosa: recognition and management - The Pharmaceutical Journal
Dystrophic Epidermolysis Bullosa in a Preschooler in a Middle Eastern Country - Harshita Prabhakaran, Judie Arulappan, Sheeba Elizabeth J, Sophia Cyril Vincent, 2023
Prevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa, Orphanet Journal of Rare Diseases
Epidermolysis bullosa: Overview
A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB). - Abstract
